Stanford researchers have developed a new method of imaging cholesteatoma, an expanding and destructive lesion of the middle ear and mastoid, based on its chemical composition.
Stanford inventors have developed a near infrared (NIR) tumor imaging platform that couples a novel rare earth cancer targeting agent and a handheld NIR-IIb fluorescence imager to enable tumor resection down to the few-cell level.
Researchers at Stanford have developed a probe, NIRDye812, which improves contrast between healthy and diseased tissues for fluorescence-guided cancer surgery applications.
An interdisciplinary team of Stanford researchers is developing a dual axis confocal (“DAC”) microscope system for in vivo imaging of tissues at the cellular scale.
Precision in surgical removal of cancer is guided by pathological assessment of resected tissues, and there is a dire need to reduce the time and distance between the critical diagnostic events and the surgical procedure.